U.S. Intrauterine Devices Market Analysis

U.S. Intrauterine Devices Market Analysis

Based on product, the market is categorized into copper IUD and hormonal IUD. The hormonal IUD segment dominated the market with a revenue of around USD 1.1 billion in 2023.
 

• Hormonal IUDs are also used for non-contraceptive health benefits, such as treating chronic pelvic pain, managing symptoms of polycystic ovary syndrome (PCOS), and providing hormone replacement therapy in perimenopausal women.
   
• Moreover, surveys and studies indicate higher satisfaction rates among women using hormonal IUDs due to their additional health benefits and fewer side effects related to menstruation, contributing to its rising preference.
   

Based on age group, the U.S. intrauterine devices market is categorized into 15-19, 20-24, 25-29, 30-34, 35-39, 40-44, and 45+. The 30-34 age group segment anticipated to dominate the market with a revenue of around USD 772.6 million in 2032.
 

• Women in the 30-34 age group are often in their peak reproductive years and are actively engaged in family planning. This age group commonly seeks reliable, long-term contraception to either space out pregnancies or to delay childbearing until later in their 30s or beyond.
   
• Moreover, compared to younger or older women, those in the 30-34 age group generally have fewer health contraindications for IUD use, making them ideal candidates for this form of contraception.
   

Based on end-use, the U.S. intrauterine devices market is categorized into hospitals, gynecology clinics, and community health care centers. The hospital segment dominated the market with a revenue share of around 49% 2023.
 

• Hospitals provide integrated care, where patients can receive consultations, diagnostic tests, and IUD insertion procedures all in one place. This convenience attracts more patients to hospital settings for their contraceptive needs.
   
• Additionally, hospitals generally serve a larger patient base compared to smaller clinics or community health centers. The high patient volume translates to a greater number of IUD insertions performed in hospitals.
   

South Atlantic intrauterine devices market accounted for USD 275.5 million in revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• The South Atlantic region has several densely populated and rapidly urbanizing areas, such as Miami, Atlanta, and Charlotte. Higher population density increases the demand for contraceptive options, including IUDs.
  
   
• Additionally, local health departments and non-profit organizations actively promote awareness about family planning and contraceptive options. Educational campaigns about the benefits and safety of IUDs contribute to increased product adoption.